Delphi Diagnostics Inc.

Delphi Diagnostics provide delphi’s sensitivity to endocrine therapy. It is a gene expression interpretive algorithm that measures potential disease progression on endocrine therapy in patients with hormone receptor positive HER2 negative breast cancer.